Sort
15,273 grants matching “antimicrobial resistance”
New Glycosylation Methods for Microbial Glycan Synthesis
$451,500Jianglong Zhu · University Of Toledo · R15 · FY2022 · GM
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$451,484Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2020 · AI
The Discovery of New Antibiotics from Deep Sea Actinomycete Bacteria
$451,467William Fenical · University Of California, San Diego · R01 · FY2009 · GM
Bioorganic Approaches Toward Novel Antimicrobial Agents and Chemotherapeutics
$451,462Steven D. Townsend · Vanderbilt University · R35 · FY2025 · GM
Bioorganic Approaches Toward Novel Antimicrobial Agents and Chemotherapeutics
$451,462Steven D. Townsend · Vanderbilt University · R35 · FY2024 · GM
Medicinal Chemistry
$451,421Toni B. Kline · University Of Washington · U54 · FY2008 · AI
Novel antibacterial agents resistant to inactivation by polyelectrolytes
$451,390Paul A Janmey · University Of Pennsylvania · R01 · FY2010 · HL
Design of pH-responsive Peptide Assembly for Acid-activatable Antimicrobial Therapy
$451,276He Dong · University Of Texas At Arlington · · FY2024 · MPS
Stimulated Innate Resistance of the Lungs to Bioterror pathogens
$451,251Axel Magnus Hook · Texas A&M University Health Science Ctr · U01 · FY2011 · AI
Development of Targeted Antipseudomonal Bactericidal Prodrugs
$451,233Christopher Akinleye Alabi · Cornell University · R01 · FY2024 · AI
Novel Antimicrobial Agents Against M. tuberculosis
$451,198Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2006 · AI
Development of Targeted Antipseudomonal Bactericidal Prodrugs
$451,001Christopher Akinleye Alabi · Cornell University · R01 · FY2025 · AI
Using Chemical Synthetic Lethality to Identify New Antimicrobial Targets in Gram-Negative Bacterial Pathogens
$451,000Mohammad R Seyedsayamdost · Princeton University · R21 · FY2025 · AI
Alveolus on a chip model of non-tuberculous mycobacteria infection
$451,000Michael Shiloh · Ut Southwestern Medical Center · R21 · FY2025 · AI
Mechanism of the Usher in Assembly and Secretion of Pili
$450,999David G Thanassi · State University New York Stony Brook · R01 · FY2017 · GM
The transcriptional circuitry controlling biofilm development in Candida albicans
$450,970Alexander D Johnson · University Of California, San Francisco · R01 · FY2016 · AI
Stimulated Innate Resistance of the Lungs to Bioterror pathogens
$450,941Axel Magnus Hook · Texas A&M University Health Science Ctr · U01 · FY2010 · AI
Novel Antimicrobial Agents Against M. tuberculosis
$450,927Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2007 · AI
Enhancing Collectin Mediated Defense Against Influenza
$450,925Kevan L Hartshorn · Boston Medical Center · R01 · FY2015 · HL
Dynamic Control of Innate Antiviral Immunity in Skin Homeostasis and Inflammation
$450,777Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2022 · AI
Inhibiting sequential biosynthetic steps of a fungal-specific organelle
$450,754Julia R Koehler · Boston Children'S Hospital · R01 · FY2022 · AI
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance
$450,732Alehandro Hoberman · University Of Pittsburgh At Pittsburgh · N01 · FY2012 · AI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
$450,732Alehandro Hoberman · University Of Pittsburgh At Pittsburgh · N01 · FY2012 · AI
Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS)
$450,726Erika M D'agata · Rhode Island Hospital · R01 · FY2021 · HS
Nanoparticle decoys for treating infections with enterotoxin-producing pathogens
$450,673Lars Eckmann · University Of California, San Diego · R33 · FY2019 · AI